CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
QSPainRelief aims to enhance chronic pain management by using advanced modeling techniques to identify effective drug combinations. The project seeks to improve pain relief while minimizing adverse effects through a novel in silico platform that predicts treatment outcomes.
Chronic pain is a complex disease suffered by about 20% of Europeans.
Up to 60% of these patients do not experience adequate pain relief from currently available analgesic combinational therapies and/or suffer confounding adverse effects.
Of the many conceivable combinations only a few have been studied in formal clinical trials.
Thus, physicians have to rely on clinical experience when treating chronic pain patients.
The vision of the QSPainRelief consortium is that alternative novel drug combi…
UNIVERSITEIT LEIDEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Lexington Ma
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Netherlands, HOUTEN
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
CONCENTRIS RESEARCH MANAGEMENT GMBH
Germany, Furstenfeldbruck
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Spain, Cerdanyola Del Valles
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
